This Article Full Text (OnlineFirst PDF) All Versions of this Article: 0003319708314250v1 0003319708314250v2 60/1/42    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Koshikawa, M. Articles by Ikeda, U. Search for Related Content PubMed PubMed Citation Articles by Koshikawa, M. Articles by Ikeda, U. Social Bookmarking                         What's this?

Elevated Osteopontin Levels in Patients With Peripheral Arterial Disease

^* To whom correspondence should be addressed. E-mail: uikeda{at}hsp.md.shinshu-u.ac.jp.

	Abstract

This study was carried out to compare concentrations of osteopontin (OPN) and osteoprotegerin (OPG) in peripheral arterial disease (PAD). The study population consisted of 200 consecutive subjects in whom both OPN/OPG and ankle–brachial index were measured. It was found that OPN levels, but not OPG levels, were significantly more increased in patients with PAD than those without PAD. Serum OPN levels were significantly lower in subjects with angiotensin converting enzyme inhibitors or angiotensin II receptor blockers than those without these agents. In this study, it has been demonstrated for the first time that serum OPN levels are related to PAD. Inhibition of renin– angiotensin system could decrease OPN levels and prevent the progression of PAD.

First published on April 2, 2008, doi:10.1177/0003319708314250

Angiology 2009;60:42.

A more recent version of this article appeared on February 1, 2009
This version was published on October 16, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?